A novel Nav1.7, Nav1.8, and Nav1.9 blocker, ANP-230, has broad analgesic efficacy in preclinical pain models with favorable safety margins
1. 系统已在2025-10-02 14:02:32对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.bbrc.2025.152197
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0006291X2500912X
其他信息:
出版社: Elsevier BV
作者: Tatsuya Kamei; Fumiaki Ishibashi; Yoshinori Takada; Atsushi Ohno; Naoko Tani; Kazuhito Ikeda; Yoshihiro Oyamada